Regulators are tightening the screws on AI, with OpenAI negotiating access and vetting procedures for model releases under government guidance, while pushing back against long-term dependence on state approvals.

There are signals of possible pauses or shifts in regulatory momentum, suggesting renewed restrictions could follow a period of hesitation.

The piece cautions that promised consumer-friendly AI improvements may be as charming as a dentist’s smile—desirable but not fully credible or affordable for most people.

Geopolitics loom large, with potential competitive advantages for China as U.S. labs navigate tightened rules.

A path forward favors collective industry action, independent guidance, and choosing the least-bad regulatory options to balance innovation and safety rather than racing to outcompete on compliance.

Early voices like Sam Altman and Dario Amodei warned about AI risks, underscoring the need for governance to address serious potential harms.

Public polls reflect skepticism toward AI firms, opposition to data centers, and worries about national security and foreign use of AI within the next two decades.

Regulatory risk has become a shared burden for major players, potentially prolonging review periods and costing billions in model development.

The core challenge is an undefined, under-resourced regulatory process, with missing standards, testing capabilities, and risk targets for frontier AI.

OpenAI’s Dean Ball notes regulators are taking AI seriously but criticizes abrupt, opaque actions and longs for a less regulated past stance.

If uncertainty delays model releases and data-center expansion, the industry could face broader disruption, slower progress, and stalled investment.

Under the current climate, the Trump administration has shifted toward restraining new AI releases, with actions against Anthropic and a pause on new model releases under Fable 5 as part of broader regulatory efforts.